Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-02 MIGAUSKY GEORGE V Director Grant or award · Stock Options (Right to Buy) +17,892 17,892
2023-06-02 Glucksmann Alexandra Director Grant or award +3,486 6,496
2023-06-02 Glucksmann Alexandra Director Grant or award · Stock Options (Right to Buy) +17,892 17,892
2023-06-02 KARABELAS ARGERIS N Director Grant or award +3,486 6,496
2023-06-02 KARABELAS ARGERIS N Director Grant or award · Stock Options (Right to Buy) +17,892 17,892
2023-06-02 Bennett Jean Director Grant or award +3,486 6,496
2023-06-02 Bennett Jean Director Grant or award · Stock Options (Right to Buy) +17,892 17,892
2023-06-02 Zachary Jennifer Director Grant or award +3,486 9,506
2023-06-02 Zachary Jennifer Director Grant or award · Stock Options (Right to Buy) +17,892 17,892
2023-05-31 Vasista Vittal Chief Financial Officer Option exercise +35,000 $0.85 $30K 215,001
2023-05-31 Vasista Vittal Chief Financial Officer Option exercise · Employee Stock Option (Right to Buy) −35,000 0
2023-01-03 Vasista Vittal Chief Financial Officer Shares withheld for taxes −1,333 $22.68 $30K 133,827
2023-01-03 Vasista Vittal Chief Financial Officer Grant or award +46,174 180,001
2023-01-03 Vasista Vittal Chief Financial Officer Grant or award · Stock Options (Right to buy) +66,233 66,233
2023-01-03 Simpson Curran Chief Oper. & Tech. Officer Shares withheld for taxes −2,076 $22.68 $47K 25,040
2023-01-03 Simpson Curran Chief Oper. & Tech. Officer Grant or award +67,945 92,985
2023-01-03 Simpson Curran Chief Oper. & Tech. Officer Grant or award · Stock Options (Right to buy) +52,986 52,986
2023-01-03 PAKOLA STEVE Chief Medical Officer Shares withheld for taxes −1,837 $22.68 $42K 15,313
2023-01-03 PAKOLA STEVE Chief Medical Officer Sale −3,138 $22.17 $70K 12,175
2023-01-03 PAKOLA STEVE Chief Medical Officer Grant or award +90,588 102,763

Page 12 of 25 · 494 trades